Top Markets
#1 Ontology Gas Ontology Gas +19.23%
#2 Status Status +13.13%
#3 Gas Gas +7.44%
#4 sBTC sBTC +5.95%
#5 Tornado Cash Tornado Cash +5.60%
#6 BCGame Coin BCGame Coin +5.45%
#7 Fake World Assets Fake World Assets +5.29%
#8 B3 (Base) B3 (Base) +5.22%
#9 aelf aelf +5.17%
#10 Derive Derive +4.65%
Coin of the day
Ontology Gas Ontology Gas
Ρυθμίσεις
Γλώσσα
Ελληνικά
Νόμισμα
USD
Θέμα
LAVA Therapeutics N.V. LAVA Therapeutics N.V.

LAVA Therapeutics N.V.

LVTX
Κατάταξη σε μετοχές #25847
LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical... LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical development phase, dedicated to pioneering novel therapies for cancer. Utilizing its proprietary Gammabody platform, the company engineers innovative bispecific antibodies. These antibodies are specifically designed to engage and harness the potent and precise capabilities of gamma delta T cells, aiming to stimulate a robust anti-tumor immune response and ultimately enhance outcomes for individuals battling cancer. Key compounds in its clinical pipeline include LAVA-051, currently undergoing Phase 1/2a trials for various hematologic malignancies such as chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia. Another front-runner, LAVA-1207, is also in Phase 1/2a clinical studies, targeting metastatic castration-resistant prostate cancer. Furthermore, LAVA Therapeutics is advancing additional Gammabody candidates: LAVA-1223, an investigational treatment for specific solid tumors that targets the epidermal growth factor receptor (EGFR), and preclinical assets LAVA-1266 and LAVA-1278, intended for a range of blood cancers. The company has also forged a research collaboration and licensing partnership with Janssen Biotech, Inc. This alliance focuses on the potential discovery and development of multi-specific antibody therapies aimed at a particular target across diverse therapeutic applications. Established in 2016, LAVA Therapeutics N.V. operates from its headquarters in Utrecht, the Netherlands.
Τιμή μετοχής
$1.74
Τελευταίος συγχρονισμός: 2025-11-28
Κεφαλαιοποίηση
$45.77M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
12.26%
Χώρα
NL
Εμπόριο LAVA Therapeutics N.V. (LVTX)

Κατηγορία

Healthcare
Ιστορικό τιμής μετοχής για την LAVA Therapeutics N.V. (LVTX)
Υψηλότερη τιμή κλεισίματος: $1.68 στις 2025-11-01

Χαμηλότερη τιμή κλεισίματος: $13.74 στις 2021-03-01
Ιστορικό τιμής μετοχής της LAVA Therapeutics N.V. από 2021 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -5.21%
2025 33.22%
2024 -17.20%
2023 -67.44%
2022 -17.89%
2021 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $119.69 -17.56%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US